EPOCH-R

EPOCH-R is a chemotherapy regimen used for the treatment of non-Hodgkin lymphoma. It is a combination of several drugs, including etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab.

Overview

EPOCH-R is a multi-drug chemotherapy regimen that is used in the treatment of certain types of non-Hodgkin lymphoma. The regimen includes the drugs etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab. These drugs work together to kill cancer cells and prevent them from growing and dividing.

Components

• Etoposide - This drug works by preventing cancer cells from repairing their DNA, which leads to cell death.
• Prednisone - Prednisone is a steroid that helps reduce inflammation and suppress the immune system.
• Vincristine - Vincristine works by stopping cancer cells from dividing and growing.
• Cyclophosphamide - This drug is a type of chemotherapy that works by damaging the DNA of cancer cells.
• Doxorubicin - Doxorubicin works by damaging the DNA of cancer cells and preventing them from dividing and growing.
• Rituximab - Rituximab is a type of immunotherapy that works by targeting and killing specific cells in the immune system.

Side Effects

Like all chemotherapy regimens, EPOCH-R can cause side effects. These can include nausea, vomiting, hair loss, fatigue, and infection. It is important for patients to discuss these potential side effects with their healthcare provider before starting treatment.

See Also

• Chemotherapy
• Non-Hodgkin lymphoma
• Cancer treatment

EPOCH-R Resources
Latest articles Most recent articles Ongoing trials	Wikipedia